Christopher Crnobori – Trademark Portfolio

Entity Type: 01

Christopher Crnobori holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include HERBIN' LIVING. The owner is based in Miami, FL.

6630 Biscayne Boulevard, Store #2

Miami, FL 33138

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Christopher Crnobori's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Christopher Crnobori have?

Christopher Crnobori has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Christopher Crnobori file in?

Christopher Crnobori files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Christopher Crnobori's most well-known trademarks?

Christopher Crnobori's registered trademark portfolio includes well-known marks such as HERBIN' LIVING. These are among 1 currently registered trademark in the portfolio.

What is Christopher Crnobori's trademark registration success rate?

Christopher Crnobori has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.